Company GeneLink, Inc.

Equities

GNLKQ

US36870F1075

Healthcare Facilities & Services

Delayed OTC Markets 01:18:16 30/01/2024 am IST 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for GeneLink, Inc. -.--% -.--%

Business Summary

Genelink, Inc. is a supplier of custom oligonucleotides. The Company offers a range of commercially available modifications, fluorescently labeled probes, and specialized probes, such as Molecular Beacons, TaqMan, and Fluorescence resonance energy transfer (FRET), as well as a variety of other molecular biology products, such as linkers, adaptors, deoxyribonucleic acid (DNA) purification and clean-up kits. The Company’s product line of gene detection systems comprises reagents and reagent systems for scientists in the detection of genetic disorders. The Company focuses on triple repeat disorders, which include fragile x, myotonic dystrophy, huntington's disease. It also specializes in the synthesis of ribonucleic acid (RNA) modified oligos, RNA fluorescent probes with quenchers, chimeric oligos containing various combinations of DNA, 2'O methyl bases and phosphorothioate linkages. It serves various industries, including research institutes, pharmaceutical companies and hospitals.

Sales per Business

USD in Million2011Weight2012Weight Delta
GeneLink
75.7 %
0 0.5 % 2 75.7 % +7,021.96%
GeneWize
24.3 %
5 99.5 % 1 24.3 % -88.84%

Sales per region

USD in Million2011Weight2012Weight Delta
United States
100.0 %
5 100.0 % 2 100.0 % -54.40%

Managers

Managers TitleAgeSince
Founder 77 21/94/21
Chief Executive Officer 77 01/99/01
Director of Finance/CFO 56 01/12/01

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 77 01/99/01
Founder 77 21/94/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 269,377,848 265,018,689 ( 98.38 %) 4,359,159 ( 1.618 %) 98.38 %

Company contact information

GeneLink, Inc.

8250 Exchange Drive Suite 120

32809, Orlando

+

http://www.genelinkbio.com
address GeneLink, Inc.(GNLKQ)
  1. Stock Market
  2. Equities
  3. GNLKQ Stock
  4. Company GeneLink, Inc.